Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

How much will Herceptin really cost?

5 references·9 citing·39 second hop

FromToDepth

this work references cited by second hop

References

2004National Institute for Clinical Excellence and its value judgments767 cited
2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis710 cited
2004Health care priority setting: principles, practice and challenges227 cited
1993Economics of Health Care Financing: The Visible Hand205 cited
2005“Yes”, “No” or “Yes, but”? Multinomial modelling of NICE decision-making122 cited

Cited by

2009Soft regulations in pharmaceutical policy making97 cited
2008Recent National and Regional Drug Reforms in Sweden85 cited
2024Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000–20: a retrospective analysis85 cited
2011European countries with small populations can obtain low prices for drugs: Lithuania as a case history78 cited
2011Economic Evaluation of Genomic Test–Directed Chemotherapy for Early-Stage Lymph Node–Positive Breast Cancer78 cited
2021Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications75 cited
2018The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra73 cited
2008Insight into recent reforms and initiatives in Austria: implications for key stakeholders70 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2010Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications69 cited